Comey accuses Trump administration of defaming him, 'lies'

June 8, 2017

Washington, Jun 8: Former FBI Director James Comey on Thursday accused the Trump administration of defaming him and telling lies about the agency, but declined to offer his opinion on whether President Donald Trump sought to obstruct justice by asking him to drop an investigation into the former national security advisor.comey

Comey told U.S. lawmakers at a hearing before a Senate panel he was confused by "the shifting explanations" given by the Trump administration for his firing on May 9.

"Although the law required no reason at all to fire the FBI director, the administration then chose to defame me and more importantly the FBI by saying that the organization was in disarray, that the workforce had lost confidence in its leader," Comey said.

"Those were lies, plain and simple, and I am so sorry that the FBI workforce had to hear them and that the American people were told that," Comey said.

Trump triggered a political firestorm on May 9 when he dismissed Comey, who was heading an FBI probe into allegations of Russian meddling into the 2016 U.S. presidential election.

In written testimony released a day before the hearing, Comey said Trump had asked him to drop an FBI investigation of former national security adviser Michael Flynn as part of the probe. Comey said Trump told him at a meeting in the White House in February, "I hope you can see your way clear to letting this go, to letting Flynn go."

Some legal experts said Comey's testimony could strengthen any impeachment case in Congress to remove Trump from office built on an allegation of obstruction of justice.

"I don't think it's for me to say whether the conversation I had with the president was an effort to obstruct. I took it as a very disturbing thing, very concerning," Comey said. "But that's a conclusion I'm sure the special counsel will work towards to try and understand what the intention was there and whether that's an offense."

The Republican president said Comey had lost the faith of his workforce, but later suggested that his dismissal was related to the Russia investigation.

"When I was appointed FBI director in 2013, I understood that I served at the pleasure of the president," Comey told the Senate Intelligence Committee in one of the most widely anticipated U.S. congressional hearing in years.

"On May the ninth, when I learned that I was fired, for that reason, I immediately came home as a private citizen. But then the explanations, the shifting explanations confused me and increasingly concerned me," Comey said.

The hearing could have significant repercussions for Trump's presidency as special counsel Robert Mueller and several congressional committees investigate alleged Russian efforts to influence the 2016 presidential election and whether Trump's campaign colluded with this.

Russia has denied such interference and the White House has denied any collusion.

The issue has dogged Trump's first months in office, with critics saying that any efforts by him to hinder the FBI probe could amount to obstruction of justice. Comey will be making his first public appearance since Trump fired him.

Photographers crowded around as Comey, wearing a dark suit, took his seat at the witness table alone at the start of the hearing in a room on Capitol Hill.

Trump planned to watch the hearing with his outside counsel Marc Kasowitz and other advisers in a dining room in the White House, a source familiar with the plan said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 6,2020

Italian researchers have claimed that they have successfully developed a vaccine to contain coronavirus (COVID-19) which is likely to work on humans, a report said.

Luigi Aurisicchio, CEO of Takis, the firm developing the medication, said that a coronavirus candidate vaccine has neutralised the virus in human cells for the first time, the Arab News reported.

"This is the most advanced stage of testing of a candidate vaccine created in Italy. Human tests are expected after this summer," Aurisicchio was quoted as saying to Italian news agency ANSA.

"According to the Spallanzani Hospital, as far as we know we are the first in the world so far to have demonstrated neutralisation of the coronavirus by a vaccine. We expect this to happen in humans too," he added.

The researchers experimented with the vaccine on mice that had successfully developed antibodies that blocked the virus from infecting the cells. They further observed that the five vaccine candidates generated a large number of antibodies, and selected two with the best results.

All of the vaccine candidates currently being developed are based on the genetic material of DNA protein "spike", the molecular tip used by the coronavirus to enter human cells.

They are injected with the so-called "electroporation" technique, which consists of an intramuscular injection followed by a brief electrical impulse, helping the vaccine break into the cells and activating the immune system, the report said.

Researchers believe that this makes their vaccine particularly effective for generating functional antibodies against the "spike" protein, in particular in the lung cells, which are the most vulnerable to coronavirus.

"We are working hard for a vaccine coming from Italian research, with an all-Italian and innovative technology, tested in Italy and made available to everyone," Aurisicchio was quoted by the Arab News report.

"In order to reach this goal, we need the support of national and international institutions and partners who may help us speed up the process," he noted.

The total number of COVID-19 infections, fatalities and recoveries since the pandemic began has risen to 213,013 in the country.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 11,2020

Apr 11: The number of global coronavirus deaths has increased to 102,753, while the total number of cases worldwide has surpassed 1.6 million, according to the latest update by the Washington-based Johns Hopkins University.

As of Saturday morning, the overall number of infections increased to 1,698,416, while the tally of those who recovered from the deadly disease stood at 376,677, according to the varsity's Center for Systems Science and Engineering (CSSE).

In terms of cases, the US had the highest in the world at 501,301, followed by Spain 158,273, Italy 147,577 and France 125,931.

Italy accounted for the highest death toll at 18,849, with the US in the second place with 18,769 fatalities.

Other countries with more than 10,000 deaths include Spain (16,081) and France (13,197).

Although the pandemic originated in China last December, it now only accounts for 3,343 deaths with 83,003 confirmed cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.